A Belgian Randomized Trial in Hepatitis C Virus-Infected Patients with Persistently Normal Alanine Aminotransferase

• Hauptverfasser: Okyay Elkilic (Verfasst von), Philippe Langlet (Verfasst von), Michael Adler (Verfasst von), Chantal De Galocsy (Verfasst von), Isabelle Colle (Verfasst von), An Reekmans (Verfasst von), JeanPierre Mulkay (Verfasst von), Hans Van Vlierberghe (Verfasst von), Nathalie Boon (Verfasst von), Geert Robaeys (Verfasst von), Luc Lasser (Verfasst von)
• Format: Buch
• Veröffentlicht: Global Journal of Clinical Virology - Peertechz Publications, 2016-10-15.
• Schlagworte: Research Article
• Online-Zugang: Connect to this object online.

<p>Persistently normal alanine aminotransferase (PNALT) is present in 30 to 40% of chronic hepatitis patients and it is generally accepted that they have no liver damage. However, some studies suggest that there are some degrees of mild to moderate histological liver damage. We evaluated the f...